AMCON Distributing Co. (DIT) - Q3 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2025 (Fiscal Q3 2025). AMCON Distributing Company operates two primary segments: a Wholesale Segment distributing consumer products (cigarettes, tobacco, confectionery, foodservice) to approximately 7,900 retail outlets across 34 states, and a Retail Segment operating 15 health food stores. The company is a non-accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|---|
| Sales | $739.6 million | $717.9 million | $2.07 billion | $1.96 billion |
| Gross Profit | $49.6 million | $48.0 million | $139.5 million | $133.6 million |
| Gross Margin | 6.7% | 6.7% | 6.7% | 6.8% |
| Operating Income | $4.9 million | $5.6 million | $9.0 million | $12.8 million |
| Net Income (Common) | $1.3 million | $1.5 million | $0.1 million | $3.1 million |
| Diluted EPS | $2.13 | $2.46 | $0.12 | $5.11 |
| Cash & Equivalents | $0.83 million (as of June 30, 2025) | |||
| Total Debt (Credit Facilities) | $154.6 million outstanding (of $241.0m limit) | |||
| Working Capital | $154.8 million ($243.7m Assets - $88.9m Liabilities) |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated sales increased 3.0% in Q3 and 5.4% YTD. The Wholesale Segment drove growth with a 2.9% Q3 increase, aided by the Arrowrock acquisition ($8.8M impact) and Richmond Master acquisition ($26.4M impact). However, cigarette carton volume declined significantly ($51.7M decrease in Q3 sales), partially offset by manufacturer price increases ($31.1M increase).
- Profitability Decline: Operating income fell 13.5% in Q3 and 29.7% YTD. This was primarily due to increased operating expenses ($2.4M increase in Q3) driven by insurance costs ($1.2M) and acquisition-related costs, which outpaced gross profit growth.
- Net Income Volatility: YTD net income plummeted 97.5% to $77,006. This sharp decline is largely attributed to a $1.5 million gain recognized in Q1 2024 related to the fair value adjustment of contingent consideration for the Burklund acquisition, which did not recur in the current period.
- Cash Flow: Net cash used in operating activities was $12.5 million for the nine months ended June 2025, compared to $26.9 million generated in the prior year period. This shift reflects changes in working capital, specifically increases in accounts receivable and inventory, and decreases in accounts payable.
Outlook, Risks, and Unusual Items
- Acquisitions: The company acquired Arrowrock Supply in January 2025 for $6.1 million. A new distribution facility in Colorado City opened in mid-July 2025 to expand western market access.
- Unusual Items: In Q1 2025, the company recognized a $1.5 million gain by writing down the contingent consideration liability for the Burklund acquisition to zero, as sales thresholds were deemed unachievable. This non-recurring item significantly inflated prior-year comparables.
- Risk Factors: Management highlights risks related to declining cigarette volumes, inflationary pressures on labor and fuel, potential FDA regulations on tobacco/vaping products, and customer credit risk. The company does not hedge interest rate or fuel cost exposure.
- Liquidity: The company maintains $86.4 million in available borrowing capacity under its credit facilities. Average interest rates on facilities were 5.77% as of June 2025.
Investor Verification Checklist
- Cigarette Volume Trends: Verify the sustainability of sales given the reported $51.7M decline in cigarette carton volume in Q3 despite price increases.
- Working Capital Efficiency: Investigate the drivers behind the $12.5M operating cash outflow, specifically the buildup in receivables and inventory versus the reduction in payables.
- Acquisition Integration: Assess the financial contribution of the Arrowrock acquisition and the new Colorado City facility against the increased operating costs.
- Debt Servicing: Confirm the impact of the 5.77% average interest rate on future earnings, especially given the high leverage relative to net income.
- Contingent Consideration: Note that the $1.5M gain from the Burklund write-down is a one-time event; future earnings should be evaluated excluding this anomaly.